Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Autre titre[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
Contributeurs/tricesRubio, Marie Thérèse; Varlet, Pauline; Allain, Vincent; Ballot, Caroline; Cuffel, Alexis; Deschamps, Marina; Ferrand, Christophe; Foguenne, Jacques; Forcade, Edouard; Huynh, Anne; Guihot, Amélie; Latouche, Jean-Baptiste; Lemarie, Claude; Martinroche, Guillaume; Morin, Florence; Nguyen Van Sang, Stéphanie; Schmit, Kathleen; Servais, Sophie; Simonetta, Federico; Yakoub-Agha, Ibrahim; Caillat Zucman, Sophie
Publié dansBulletin du cancer, vol. 108, no. 12S, p. S53-S64
Date de publication2021-12
Date de mise en ligne2021-07-09
Résumé
Mots-clés
- Biomarker
- Biomarqueurs
- CAR-T cells
- Cellules CAR-T
- Immune monitoring
- Prediction
- Prédiction
- Recommandations
- Recommendations
- Suivi immunologique
- Bacterial Infections / etiology
- Blood Component Removal
- Cytokine Release Syndrome / immunology
- Flow Cytometry
- Hematologic Neoplasms / immunology
- Hematologic Neoplasms / therapy
- Humans
- Immune Reconstitution
- Immunity, Cellular
- Immunotherapy, Adoptive / adverse effects
- Leukemia, Lymphocytic, Chronic, B-Cell / immunology
- Leukemia, Lymphocytic, Chronic, B-Cell / therapy
- Lymphocyte Depletion
- Lymphoma, Large B-Cell, Diffuse / immunology
- Lymphoma, Large B-Cell, Diffuse / therapy
- Monitoring, Immunologic / methods
- Monitoring, Immunologic / standards
- Multiple Myeloma / immunology
- Multiple Myeloma / therapy
- Mycoses / etiology
- Neurotoxicity Syndromes / immunology
- Polymerase Chain Reaction
- Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
- Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
- Recurrence
- Societies, Medical
- T-Lymphocytes / drug effects
- T-Lymphocytes / transplantation
- Virus Diseases / etiology
Structure d'affiliation
Citation (format ISO)
RUBIO, Marie Thérèse et al. Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). In: Bulletin du cancer, 2021, vol. 108, n° 12S, p. S53–S64. doi: 10.1016/j.bulcan.2021.04.008
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:163885
- DOI : 10.1016/j.bulcan.2021.04.008
- PMID : 34253335
ISSN du journal0007-4551